首页|期刊导航|农业生物技术学报|动物生物反应器的研究进展与应用

动物生物反应器的研究进展与应用OA

Research Progress and Application of Animal Bioreactors

中文摘要英文摘要

动物生物反应器是一种利用转基因动物的特定器官(如乳腺,血液,膀胱等)作为生物合成"工厂",生产高附加值生物活性物质的前沿技术.随着生物医药产业对重组蛋白需求的持续增长,传统的微生物表达系统和细胞培养技术因在翻译后修饰能力方面的局限性或生产成本过高,逐渐显现发展瓶颈.相比之下,动物生物反应器具备生产成本低、表达产量高以及能够实现复杂翻译后修饰等优势,已成为突破上述技术瓶颈的重要途径.本文以多基因协同表达、CRISPR/Cas9精准基因编辑、非侵入性产物采集、伦理安全一体化为前沿技术融合视角,系统综述了乳腺、家蚕(Bombyx mori)丝腺、禽类蛋体及膀胱等主要动物生物反应器的技术原理与应用进展;比较分析了不同表达标签的选择策略;针对当前存在的转基因效率偏低、动物伦理争议以及安全性评估体系不完善等挑战,提出了基于CRISPR/Cas9基因编辑技术优化和非侵入性产物采集方法的改进路径,并展望了该技术在多基因协同表达调控及生物医药规模化生产中的未来发展方向,为重组药用蛋白动物生物反应器的基础研究、体系优化及产业化开发提供理论参考.

Animal bioreactors represent an advanced biotechnology platform that uses specific organs of transgenic animals(such as mammary gland,blood,bladder,etc.)as biosynthesis"factories"to produce high value-added bioactive substances.With the continuous growth in demand for recombinant proteins in the biopharmaceutical industry,traditional microbial expression systems and cell culture technologies have gradually encountered development bottlenecks due to limitations in post-translational modification or excessively high production costs.In contrast,animal bioreactors possess the advantages of low production cost,high expression yield,and the ability to achieve complex post-translational modifications,thus becoming an important approach to break through the above technical bottlenecks.From an integrated perspective of cutting-edge technologies including multi-gene co-expression,CRISPR/Cas9 precise gene editing,non-invasive product harvesting,and integrated ethical and safety evaluation,this review systematically reviews the technical principles and application progress of major animal bioreactors such as mammary gland,silkworm(Bombyx mori)silk gland,avian eggs,and bladder;Compares and analyzes the selection strategies of different expression tags.In response to current challenges including low transgenic efficiency,controversies over animal ethics,and imperfect safety evaluation systems,this review proposes improvement strategies based on optimized CRISPR/Cas9 gene editing and non-invasive product collection methods,and prospects future development directions of these technology in the regulation of multi-gene co-expression and large-scale production of biopharmaceuticals,which provides theoretical references for fundamental research,system optimization and industrial development of animal bioreactors for recombinant medicinal proteins.

马江莅;宋晓慧;孙祺;薛画诗;朱悦悦;杨藩

西北农林科技大学 动物医学院/陕西省干细胞工程技术研究中心,杨凌 712100西北农林科技大学 动物医学院/陕西省干细胞工程技术研究中心,杨凌 712100西北农林科技大学 动物医学院/陕西省干细胞工程技术研究中心,杨凌 712100西北农林科技大学 动物医学院/陕西省干细胞工程技术研究中心,杨凌 712100西北农林科技大学 动物医学院/陕西省干细胞工程技术研究中心,杨凌 712100西北农林科技大学 动物医学院/陕西省干细胞工程技术研究中心,杨凌 712100

农业科技

动物生物反应器转基因技术表达标签生物医药

Animal bioreactorTransgenic technologyExpression tagBiomedicine

《农业生物技术学报》 2026 (10)

2193-2207,15

国家重点研发计划-青年科学家项目(2024YFA0920500)

10.3969/j.issn.1674-7968.2026.10.012

评论